Established in 2019 through a collaboration between Genovior Biotech Corporation and New Hope Group, a Fortune 500 company, Fujian Genohope Biotech Ltd. stands as a premier Contract Injectable Drug Manufacturing Organization in China. The company is dedicated to fostering a global environment where high-value medicines are accessible. Genohope specializes primarily in Diabetes & Obesity and Oncology products of high value. The...
Established in 2019 through a collaboration between Genovior Biotech Corporation and New Hope Group, a Fortune 500 company, Fujian Genohope Biotech Ltd. stands as a premier Contract Injectable Drug Manufacturing Organization in China. The company is dedicated to fostering a global environment where high-value medicines are accessible. Genohope specializes primarily in Diabetes & Obesity and Oncology products of high value. The company offers customization, development, and manufacturing services for both High Potency Active Pharmaceutical Ingredients (HP APIs) and a variety of Injectable Finished Dosage Forms (FDF).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.